1. Copyright © 2006 American Medical Association. All rights reserved.
From: Improved Adherence and Less Toxicity With Rifampin vs Isoniazid for Treatment of Latent TuberculosisA Retrospective Study
Arch Intern Med. 2006;166(17): doi: /archinte
Figure Legend:
Flow diagram of the study population. LTBI indicates latent tuberculosis infection; 4-RIF, 4-month regimen of rifampin therapy; and 9-INH, 9-month regimen of isoniazid therapy.
Date of download: 10/27/2017
Copyright © 2006 American Medical Association. All rights reserved.

2. Copyright © 2006 American Medical Association. All rights reserved.
From: Improved Adherence and Less Toxicity With Rifampin vs Isoniazid for Treatment of Latent TuberculosisA Retrospective Study
Arch Intern Med. 2006;166(17): doi: /archinte
Figure Legend:
Percentage of patients completing treatment by month for isoniazid and rifampin groups. Error bars represent 95% confidence intervals. 4-RIF indicates 4-month regimen of rifampin therapy; and 9-INH, 9-month regimen of isoniazid therapy.
Date of download: 10/27/2017
Copyright © 2006 American Medical Association. All rights reserved.